Genomic Medicine Sweden (GMS) and the Danish National Genome Center (DNGC) have renewed their memorandum of understanding to promote the development of personalised medicine in Sweden and Denmark. The strategic collaboration aims to improve the conditions for...
Using a new technique, long-read sequencing, that allows DNA to be analyzed in much greater detail than before, a team of Swedish clinicians and researchers has discovered an unexpected complexity in chromosomal abnormalities. The study opens the door to more precise...
Accurate identification of disease-causing genetic alterations is crucial for refining the diagnosis and treatment of blood cancers. The broad gene panel for myeloid malignancies, a subset of blood cancers, developed by Genomic Medicine Sweden in collaboration with...
The cost of whole-genome sequencing is approaching that of the traditional genetic tests currently used for patients diagnosed with acute leukemia, according to a new study published in the Journal of Medical Economics. With costs falling and whole-genome sequencing...
The national steering group of Genomic Medicine Sweden (GMS) has appointed Samuli Ripatti, Jayne Hehir-Kwa, Christian Gilissen, Augusto Rendon, Tony Håndstad and Mathias Ekman as members of the new GMS Informatics Advisory Board. “We are delighted to welcome this...
För att ge den bästa upplevelsen använder vi teknologier som cookies för att lagra och/eller få åtkomst till enhetsinformation. Genom att samtycka till dessa teknologier kan vi behandla data såsom surfbeteende eller unika ID:n på denna webbplats.
Anpassa samtycke
För att ge den bästa upplevelsen använder vi teknologier som cookies för att lagra och/eller få åtkomst till enhetsinformation. Genom att samtycka till dessa teknologier kan vi behandla data såsom surfbeteende eller unika ID:n på denna webbplats.
